Concepedia

Steven H. Olson

SH

Statistics

Publications

46

Citations

3.5K

H-Index

32

Active since

1991

Affiliations

University of California, San Francisco(Current)

Amgen (United States)

Institute for Neurodegenerative Disorders

Merck & Co., Inc., Rahway, NJ, USA (United States)

Discovery Institute

Steven H. Olson is an author at University of California, San Francisco specializing in drug discovery, medicinal chemistry, and pharmacology.

ORCID

Publications per year

1991–2025

46

Publications

46

11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice

Anne Hermanowski‐Vosatka, James M. Balkovec, Kang Cheng et al. · The Journal of Experimental Medicine · 2005 · 363 citations · Full text

, , +17

Discovery of AMG 232, a Potent, Selective, and Orally Bioavailable MDM2–p53 Inhibitor in Clinical Development

Daqing Sun, Zhihong Li, Yosup Rew et al. · Journal of Medicinal Chemistry · 2014 · 296 citations · Full text

, , +7

Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-β-lactamase

Jeffrey H. Toney, Paula M.D. Fitzgerald, Nandini Grover-Sharma et al. · Chemistry & Biology · 1998 · 239 citations · Full text

, , +15

Succinic Acids as Potent Inhibitors of Plasmid-borne IMP-1 Metallo-β-lactamase

Jeffrey H. Toney, Gail G. Hammond, Paula M.D. Fitzgerald et al. · Journal of Biological Chemistry · 2001 · 200 citations · Full text

, , +16

Tau prions from Alzheimer’s disease and chronic traumatic encephalopathy patients propagate in cultured cells

Amanda L. Woerman, Atsushi Aoyagi, Smita S. Patel et al. · Proceedings of the National Academy of Sciences · 2016 · 174 citations · Full text

, , +17

1–5 of 46